The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche
Open accessAbstract
Tumor cell metastasis is facilitated by "premetastatic niches" formed in destination organs by invading bone marrow-derived cells (BMDCs). Lysyl oxidase (LOX) is critical for premetastatic niche formation. LOX secreted by hypoxic breast tumor cells accumulates at premetastatic sites, crosslinks collagen IV in the basement membrane, and is essential for CD11b+ myeloid cell recruitment. CD11b+ cells adhere to crosslinked collagen IV and produce matrix metalloproteinase-2, which cleaves collagen, enhancing the invasion and recruitment of BMDCs and metastasizing tumor cells. LOX inhibition prevents CD11b+ cell recruitment and metastatic growth. CD11b+ cells and LOX also colocalize in biopsies of human metastases. Our findings demonstrate a critical role for LOX in premetastatic niche formation and support targeting LOX for the treatment and prevention of metastatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Specifically, hypoxia-induced lysyl oxidase contributes to the pre-metastatic niche in a process that includes collagen crosslinking and recruitment of CD11b + myeloid cells (Erler et al., 2009).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Erler et al., 2009
In the citing paper
“The BMDCs promote metastasis by producing chemokines that recruit tumor cells to the lung by mechanisms that include stimulation of tumor cell extravasation”
From Hypoxic control of metastasis (2016) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
Self-citationRetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,333
Tensional homeostasis and the malignant phenotype
Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.010 · Cited by 3,941
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J. S., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,677
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662 · cited 1×
“Increased metastases, enhanced tumor progression, and decreased patient survival have been associated with primary tumors that contain large numbers of poorly oxygenated (hypoxic) tumor cells (Cairns et al., 2003; Hockel and Vaupel, 2001; Pouyssegur et al., 2006).”
Background
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 999
Adaptive Fibrogenic Reprogramming of Osteosarcoma Stem Cells Promotes Metastatic Growth
Zhang, W., Zhao, J.-M., Lin, J., Hu, C.-Z., Zhang, J., YANG, W.-L., Zhang, J., Zhang, J., & Zhu, J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.103 · Cited by 40
Long non-coding RNA and extracellular matrix: the hidden players in cancer-stroma cross-talk
D’Angelo, E., & Agostini, M. (2018) · Non-coding RNA Research · doi:10.1016/j.ncrna.2018.08.002 · Cited by 40
Urooj, T., Wasim, B., Mushtaq, S., Shah, S. N. N., & Shah, M. (2019) · Current Cancer Drug Targets · doi:10.2174/1568009620666191220151856 · Cited by 39
Metabolic Plasticity and Epithelial-Mesenchymal Transition
Thomson, T. M., Balcells, C. D., & Cascante, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070967 · Cited by 39
Hypoxia as a Cause of Treatment Failure in Non–Small Cell Carcinoma of the Lung
Brustugun, O. T. (2014) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2014.11.006 · Cited by 38
Cross-Talk between Tumor Cells and the Microenvironment at the Metastatic Niche
Carlini, M. J., Lorenzo, M. S. D., & Puricelli, L. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111798377058 · Cited by 37
Ritchie, S., Reed, D. A., Pereira, B., & Timpson, P. (2021) · Faculty Reviews · doi:10.12703/r/10-4 · Cited by 40
Myeloid Cells in MetastasisPreprint
Swierczak, A., & Pollard, J. W. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a038026 · Cited by 39
Li, Q., Zhang, X.-X., Hu, L.-P., Li, D., Li, D.-X., Wang, X., Jiang, S.-H., Li, H., Yang, M.-W., Jiang, Y.-S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36521-0 · Cited by 39
Targeting lysyl oxidase for molecular imaging in breast cancer
Wuest, M., Kuchar, M., Sharma, S. K., Richter, S., Hamann, I., Wang, M., Vos, L. J., Mackey, J. R., Wuest, F. R., & Löser, R. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0609-9 · Cited by 38
Redox signaling at invasive microdomains in cancer cells
Díaz, B., & Courtneidge, S. A. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.016 · Cited by 38
Premetastatic Lung “Niche”: Is Vascular Endothelial Growth Factor Receptor 1 Activation Required?
Duda, D. G., & Jain, R. K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0119 · Cited by 37
The sleeping ugly: Tumour microenvironment's act to make or break the spell of dormancy
Gay, L. J., & Malanchi, I. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.05.002 · Cited by 35
5-Lipoxygenase: Its involvement in gastrointestinal malignancies
Merchant, N., Bhaskar, L. V., Momin, S., Peela, S., Reddy, A. B. M., & Nagaraju, G. P. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.05.012 · Cited by 37
Chae, H. (2011) · Oncology Letters · doi:10.3892/ol.2011.353 · Cited by 37
A Digest on the Role of the Tumor Microenvironment in Gastrointestinal Cancers
Augsten, M., Hägglöf, C., Peña, C., & Östman, A. (2010) · Cancer Microenvironment · doi:10.1007/s12307-010-0040-9 · Cited by 38
Henríquez, J. A., Sleeman, J. P., & Garvalov, B. K. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9930-x · Cited by 37
Fraga, A. M., Ribeiro, R. J. T., Coelho, A., Vizcaino, J. R., Coutinho, H., Lopes, J. M., Príncipe, P., Lobato, C., Lopes, C., & Medeiros, R. (2017) · BMC Urology · doi:10.1186/s12894-017-0201-y · Cited by 37
Li, M., Bu, X., Cai, B., Liang, P., Li, K., Qu, X., & Shen, L. (2018) · Oncology Reports · doi:10.3892/or.2018.6882 · Cited by 40
Peptide nano-blanket impedes fibroblasts activation and subsequent formation of pre-metastatic niche
Zhou, Y., Ke, P., Bao, X., Wu, H., Xia, Y., Zhang, Z., Zhong, H., Dai, Q., Wu, L., Wang, T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30634-8 · Cited by 36
Molecular Pathogenesis of Sporadic Melanoma and Melanoma-Initiating Cells
Kong, Y., Kumar, S. M., & Xu, X. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2009-0418-rar.1 · Cited by 36
Tumor‐Induced Local and Systemic Impact on Blood Vessel Function
Cedervall, J., Dimberg, A., & Olsson, A. (2015) · Mediators of Inflammation · doi:10.1155/2015/418290 · Cited by 36
Can oncology recapitulate paleontology? Lessons from species extinctions
Walther, V., Hiley, C. T., Shibata, D. K., Swanton, C., Turner, P. E., & Maley, C. C. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.12 · Cited by 37
Premetastatic niche: ready for new therapeutic interventions?
Zoccoli, A., Iuliani, M., Pantano, F., Imperatori, M., Intagliata, S., Vincenzi, B., Marchetti, P., Papapietro, N., Denaro, V., Tonini, G., et al. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.656092 · Cited by 34
Mignogna, C., Signorelli, F., Vismara, M. F. M., Zeppa, P., Camastra, C., Barni, T., Donato, G., & Vito, A. D. (2016) · Pathology - Research and Practice · doi:10.1016/j.prp.2016.02.020 · Cited by 35
The changing paradigm of tumour response to irradiation
Hill, R. P. (2016) · British Journal of Radiology · doi:10.1259/bjr.20160474 · Cited by 38
Dower, C. M., Bhat, N., Wang, W., & Wang, H. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3458 · Cited by 35
Tailoring Natural Killer cell immunotherapy to the tumour microenvironment
Barrow, A. D., & Colonna, M. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.09.001 · Cited by 36
Microenvironment Influences Cancer Cell Mechanics from Tumor Growth to Metastasis
Ghosh, D., & Dawson, M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-95294-9_5 · Cited by 36
Franchi, M., Masola, V., Bellin, G., Onisto, M., Karamanos, K., & Piperigkou, Z. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020213 · Cited by 37
Pericytes cross-talks within the tumor microenvironment
Picoli, C. C., Gonçalves, B. Ô. P., Santos, G. S. P., Rocha, B. G. S., Costa, A. C., Resende, R. R., & Birbrair, A. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188608 · Cited by 35
Mechanism of action and clinical activity of tasquinimod in castrate-resistant prostate cancer
Пили, Р., Ustwani, O. A., Gupta, N., & Shen, L. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s53524 · Cited by 35
Molecular Mechanism Underlying Lymphatic Metastasis in Pancreatic Cancer
Xiao, Z., Luo, G., Liu, C., Wu, C., Liu, L., Liu, Z., Ni, Q., Long, J., & Yu, X. (2014) · BioMed Research International · doi:10.1155/2014/925845 · Cited by 35
Djidja, M., Chang, J., Hadjiprocopis, A., Schmich, F., Sinclair, J., Mršnik, M., Schoof, E. M., Barker, H. E., Linding, R., Jørgensen, C., et al. (2014) · Journal of Proteome Research · doi:10.1021/pr401056c · Cited by 35
Self-citationDeep, G., Kumar, R., Jain, A., Agarwal, C., & Agarwal, R. (2014) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.05.002 · Cited by 34
Shiau, J., Chang, Y.-Q., Nakagawa‐Goto, K., Lee, K., & Shyur, L. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00398 · Cited by 34
Kelsh, R., & McKeown‐Longo, P. J. (2013) · PubMed · Cited by 34
Shaikat, A. H., Azad, S. M. A. K., Tamim, M. A. R., Ullah, M. S., Amin, M. N., Sabbir, M. K., Tarun, M. T. I., Mostaq, M. S., Sabrin, S., Mahmud, M. Z., et al. (2025) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2025.07.003 · Cited by 37
English, W., Lunt, S. J., Fisher, M., Lefley, D. V., Dhingra, M., Lee, Y., Bingham, K., Hurrell, J. E., Lyons, S. K., Kanthou, C., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-0255 · Cited by 32
Sanada, T., Islam, A., Kaminota, T., Kirino, Y., Tanimoto, R., Yoshimitsu, H., Yano, H., Mizuno, Y., Okada, M., Mitani, S., et al. (2019) · The Laryngoscope · doi:10.1002/lary.28142 · Cited by 33
Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment
Lappano, R., Todd, L. A., Stanic, M., Cai, Q., Maggiolini, M., Marincola, F., & Pietrobon, V. (2022) · Cancers · doi:10.3390/cancers14030539 · Cited by 32
Present and future of metal nanoparticles in tumor ablation therapy
Lou, W., Xie, L., Xu, L., Xu, M., Xu, F., Zhao, Q., & Jiang, T. (2023) · Nanoscale · doi:10.1039/d3nr04362b · Cited by 33
Jiang, D., Zhao, J., Zheng, J., Zhao, Y., Le, M., Qin, D., Huang, Q., Huang, J., Zhao, Q., Wang, L., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103346 · Cited by 35
Determination of cell uptake pathways for tumor inhibitor lysyl oxidase propeptide
Ozdener, G. B., Bais, M. V., & Trackman, P. C. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.07.005 · Cited by 33
Periostin Functions as a Scaffold for Assembly of Extracellular Proteins
Kii, I. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-6657-4_3 · Cited by 32
Hsu, H., Wang, C., Hsieh, P.-Y., Fang, J.-H., & Chen, Y. (2019) · Journal of Cancer · doi:10.7150/jca.35821 · Cited by 31
Sanmartin, M. C., Borzone, F. R., Giorello, M. B., Pacienza, N., Yannarelli, G., & Chasseing, N. A. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103416 · Cited by 34
Zhang, C., Li, Q. X., Xu, Q., Dong, W., Li, C., Deng, B., Gong, J., Zhang, L., & Jin, J. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02748-4 · Cited by 31
Neutrophil as a multifunctional relay in immune system
Dolgushin, I. I., Анатольевна, М. Е., Savochkina, A. Y., & Kuznetsova, E. K. (2019) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-2019-1-9-38 · Cited by 37
Tian, H., Pang, J., Qin, K., Yuan, W.-M., Kong, J., Ma, H., He, J., Yang, X., Luo, Y., Lu, Y., et al. (2019) · Biotechnology Journal · doi:10.1002/biot.201900107 · Cited by 32
Medeiros, B., Goodale, D. B., Postenka, C. O., Lowes, L. E., Kiser, P. K., Hearn, S., Salmond, N., Williams, K. C., & Allan, A. L. (2020) · Cancers · doi:10.3390/cancers12010172 · Cited by 31
Yang, L., Li, T., Shi, H., Zhou, Z., Huang, Z., & Lei, X. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1848543 · Cited by 31
Mokbel, K., Patani, N., Jiang, W. G., & Newbold, R. F. (2010) · Journal of Carcinogenesis · doi:10.4103/1477-3163.72505 · Cited by 31
Hypoxia and Metastasis in Breast Cancer
Rundqvist, H., & Johnson, R. S. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_77 · Cited by 33
RIP4 inhibits STAT3 signaling to sustain lung adenocarcinoma differentiation
Kopparam, J., Chiffelle, J., Angelino, P., Piersigilli, A., Zangger, N., Delorenzi, M., & Meylan, E. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.81 · Cited by 31
Peng, C., Liu, J., Yang, G., & Li, Y. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s143871 · Cited by 31
Skhinas, J. N., & Cox, T. R. (2017) · Cell Adhesion & Migration · doi:10.1080/19336918.2017.1405208 · Cited by 31
Self-citationStresses in the metastatic cascade: molecular mechanisms and therapeutic opportunitiesPreprint
Shen, M., & Kang, Y. (2020) · Genes & Development · doi:10.1101/gad.343251.120 · Cited by 31
McGregor, T. L., Gurnett, C. A., Dobbs, M. B., Wise, C. A., Morcuende, J. A., Morgan, T. M., Menon, R., & Muglia, L. J. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-92 · Cited by 30
The Inhibition of Vessel Co-Option as an Emerging Strategy for Cancer Therapy
Carrera-Aguado, I., Marcos-Zazo, L., Carrancio-Salán, P., Guerra-Paes, E., Sánchez‐Juanes, F., & Muñoz‐Félix, J. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020921 · Cited by 31
The role of lysyl oxidase, the extracellular matrix and the pre-metastatic niche in bone metastasis
Gartland, A., Erler, J. T., & Cox, T. R. (2016) · Journal of bone oncology · doi:10.1016/j.jbo.2016.04.001 · Cited by 30
Self-citationTodd, V. M., Omokehinde, T., & Johnson, R. W. (2019) · Cancer Reports · doi:10.1002/cnr2.1156 · Cited by 30
Yi, X., Yan, Y., Li, L., Li, Q., Xiang, Y., & Huang, Y. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202010283 · Cited by 30
Pro- and Antiangiogenic Factors in Gliomas: Implications for Novel Therapeutic Possibilities
Groblewska, M., & Mroczko, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116126 · Cited by 35
Inflammation and skeletal metastasis
Roca, H., & McCauley, L. K. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.75 · Cited by 29
Travelling under pressure - hypoxia and shear stress in the metastatic journey
Ildız, E. S., Gvozdenovic, A., Kovacs, W. J., & Aceto, N. (2023) · Clinical & Experimental Metastasis · doi:10.1007/s10585-023-10224-8 · Cited by 31
Epigenetic regulation of breast cancer metastasis
Thakur, C., Qiu, Y., Pawar, A. S., & Chen, F. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10146-7 · Cited by 31
Lysyl oxidase-like 3b is critical for cartilage maturation during zebrafish craniofacial development
van Boxtel, A. L., Gansner, J. M., Hakvoort, H. W. J., Snell, H. D., Legler, J., & Gitlin, J. D. (2011) · Matrix Biology · doi:10.1016/j.matbio.2010.12.002 · Cited by 29
Influence of Immune Myeloid Cells on the Extracellular Matrix During Cancer Metastasis
Jiang, D. G., & Lim, S. Y. (2016) · Cancer Microenvironment · doi:10.1007/s12307-016-0181-6 · Cited by 29
The SphKs/S1P/S1PR1 axis in immunity and cancer: more ore to be mined
Jin, L., Liu, W.-R., Tian, M., Fan, J., & Shi, Y. (2016) · World Journal of Surgical Oncology · doi:10.1186/s12957-016-0884-7 · Cited by 31
Retrospective analysis of sites of recurrence in stage I epithelial ovarian cancer
Hirose, S., Tanabe, H., Nagayoshi, Y., Hirata, Y., Narui, C., Ochiai, K., Isonishi, S., Takano, H., & Okamoto, A. (2018) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2018.29.e37 · Cited by 29
Hypoxia and the Metastatic Niche
Chan, C. Y., Yuen, V. W., & Wong, C. C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_7 · Cited by 30
Engineered models of tumor metastasis with immune cell contributions
Graney, P. L., Tavakol, D. N., Chramiec, A. G., Ronaldson-Bouchard, K., & Vunjak‐Novakovic, G. (2021) · iScience · doi:10.1016/j.isci.2021.102179 · Cited by 30
Molecular Mechanisms of Tumor Immunomodulation in the Microenvironment of Colorectal Cancer
Plundrich, D., Chikhladze, S., Fichtner‐Feigl, S., Feuerstein, R., & Briquez, P. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052782 · Cited by 31
CD8+ T‐cell immunosurveillance constrains lymphoid premetastatic myeloid cell accumulation
Zhang, W., Zhang, C., Li, W., Deng, J., Herrmann, A., Priceman, S. J., Liang, W. P., Shen, S., Pal, S. K., Hoon, D. S. �., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201444467 · Cited by 29
Grossman, I., Alon, A., Ilani, T., & Fass, D. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.07.011 · Cited by 29
Molecular mechanisms of liver metastasis
Kawada, K., Hasegawa, S., Murakami, T., Itatani, Y., Hosogi, H., Sonoshita, M., Kitamura, T., Fujishita, T., Iwamoto, M., Matsumoto, T., et al. (2011) · International Journal of Clinical Oncology · doi:10.1007/s10147-011-0307-2 · Cited by 32
Role of mesenchymal cells in the natural history of ovarian cancer: a review
Touboul, C., Vidal, F., Pasquier, J., Lis, R., & Rafii, A. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0271-5 · Cited by 29
Motohara, T., Fujimoto, K., Tayama, S., Narantuya, D., Sakaguchi, I., Tashiro, H., & Katabuchi, H. (2016) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001420 · Cited by 29
Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics
Janin, M., Dávalos, V., & Esteller, M. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10120-3 · Cited by 30
Wegwitz, F., Kluth, M.-A., Maenz, C., Otto, B., Gruner, K., Heinlein, C., Kühl, M., Warnecke, G., Schumacher, U., Deppert, W., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012103 · Cited by 27
Role of chemokines in metastatic niche: new insights along with a diagnostic and prognostic approach
Rezaeeyan, H., Shirzad, R., McKee, T. D., & Saki, N. (2018) · Apmis · doi:10.1111/apm.12818 · Cited by 29
Monocytes and Macrophages in Cancer: Unsuspected Roles
Gouveia-Fernandes, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_9 · Cited by 28
Wiecheć, E., Matić, N., Ali, A., & Roberg, K. B. (2022) · Oncology Reports · doi:10.3892/or.2022.8269 · Cited by 28
Fonta, C. M., Loustau, T., Li, C., Surendran, S. P., Hansen, U. J., Murdamoothoo, D., Benn, M. C., Velázquez-Quesada, I., Carapito, R., Orend, G., et al. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.01.002 · Cited by 29
The pre-metastatic niche: is metastasis random?
Cox, T. R., Gartland, A., & Erler, J. T. (2012) · BoneKEy Reports · doi:10.1038/bonekey.2012.80 · Cited by 28
Self-citationHepatic consequences of vascular adhesion protein-1 expression
Weston, C. J., & Adams, D. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0647-0 · Cited by 26
Zeng, Q., Fu, J. L., Korrer, M. J., Gorbounov, M., Murray, P. J., Pardoll, D., Masica, D. L., & Kim, Y. J. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0543 · Cited by 26
Epithelial-Mesenchymal Plasticity in Organotropism Metastasis and Tumor Immune Escape
Nan, X., Wang, J., Liu, H. N., Wong, S. T. C., & Zhao, H. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050747 · Cited by 27
Snail-Family Proteins: Role in Carcinogenesis and Prospects for Antitumor Therapy
Yastrebova, M. A., Khamidullina, A. I., Tatarskiy, V. V., & Scherbakov, A. M. (2021) · Acta Naturae · doi:10.32607/actanaturae.11062 · Cited by 28
Li, Z., Shi, L., Li, X., Wang, X., Wang, H., & Liu, Y. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00689-z · Cited by 27
Bhattacharyya, S. K., Jana, I. D., Pandey, N., Biswas, D., Girigoswami, A., Dey, T., Banerjee, S., Ray, S. K., Mondal, A., Mukherjee, G., et al. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.2c02841 · Cited by 27
Lysyl oxidase activity regulates oncogenic stress response and tumorigenesis
Wiel, C., Augert, A., Vincent, D. F., Gitenay, D., Vindrieux, D., Calvé, B. L., Arfi, V., Lallet-Daher, H., Reynaud, C., Treilleux, I., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.382 · Cited by 27
Overexpression of Lox in triple-negative breast cancer
Leo, C., Cotic, C., Pomp, V., Fink, D. A., & Varga, Z. (2018) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2018.03.009 · Cited by 27
Choi, J., Chung, T., Rhee, H., Kim, Y., Jeon, Y., Yoo, J. E., Noh, S., Han, D. H., & Park, Y. N. (2018) · Gut and Liver · doi:10.5009/gnl17569 · Cited by 27
Li, X., Hu, S., Zhu, Q., Yao, G., Yao, J., Li, J., Wang, Y., Ding, Y., Qi, J., Xu, R., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154749 · Cited by 26
Antitumor Activity and Mechanistic Insights of a Mitochondria-Targeting Cu(I) Complex
Xu, S., Hao, Y., Xu, X., Huang, L., Liang, Y., Liao, J., Yang, J., Zhou, Y., Huang, M., Du, K., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02018 · Cited by 28
Neutrophil-Derived Interleukin 16 in Premetastatic Lungs Promotes Breast Tumor Cell Seeding
Donati, K., Sépult, C., Rocks, N., Blacher, S., Gerard, C. M., Noël, A., & Cataldo, D. D. (2017) · Cancer Growth and Metastasis · doi:10.1177/1179064417738513 · Cited by 26
Restriction of drug transport by the tumor environment
Nandigama, R., Upcin, B., Aktas, B. H., Ergün, S., & Henke, E. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1744-z · Cited by 28
Nicolini, A., Rossi, G., Ferrari, P., & Carpi, A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.009 · Cited by 26
Metadata
- Authors
- Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., Le, Q.-T., & Giaccia, A. J.
- Affiliations
- Institute of Cancer Research (GB)
- BC Cancer Agency (CA)
- Stanford Medicine (US)
- Corresponding author
- Giaccia, Amato J.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 15
- Issue
- 1
- Pages
- 35-44
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC3050620
- OpenAlex
- W2159744630
- Cited by
- 1,231
- References
- 40
- Citations by year
- 2026: 38 · 2025: 45 · 2024: 61 · 2023: 66 · 2022: 62 · 2021: 82 · 2020: 78 · 2019: 96 · 2018: 80 · 2017: 71 · 2016: 90 · 2015: 72 · 2014: 74 · 2013: 87 · 2012: 72
- FWCI
- 37.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Cancer Research UK
- National Cancer Institute (P01CA067166, T32CA009151)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- lysyl oxidase, pre-metastatic niche, metastasis, bone marrow-derived cells, hypoxia, breast cancer, CD11b+ myeloid cells, basement membrane, MMP-2, collagen degradation, metastasis prevention
- MeSH terms
- Animals, Hypoxia, Basement Membrane, Bone Marrow Cells, Breast Neoplasms, Cell Differentiation, Cell Movement, Cell Separation, Enzyme Activation, Humans, Lung Neoplasms, Protein-Lysine 6-Oxidase, Mice, Nude, Neoplasm Metastasis, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Disease Progression, Matrix Metalloproteinase 2, Myeloid Cells, Xenograft Model Antitumor Assays, Collagen Type IV, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review